Luminec Holdings has revealed another round of innovative products based on our core technologies, TriAmino™ and TAFA400™, with enhanced absorption and effectiveness provided by SK-713™.
Click on an image to zoom in.
LUMINEC HOLDINGS, INC.
John Everding, Founder
Dr. Michael Chase, Chairman Luminec Holdings Corp.
Eric Kim, CFO
Dra. Susana Alcazar-Leyva, Chief Scientific Officer
Christopher Neville, CEO Luminec Pharmaceuticals
Chris@luminecholdings.com – info@luminecholdings.com
+61 433 230 530 – What’s App (Sydney: GMT +11)
MANUFACTURING PARTNERS
U.S. Manufacturing
Luminec Corporation
Vista, CA
Austin Vernaci, Executive Director
Mexico / Central & South America
Manufacturing & Distribution
Philippines Distribution
Catala Corporation
India Distribution
Pending
Ukraine Distribution
Viktor Peshcherin, Executive Advisor
ASSOCIATED COMPANIES
SPECIAL THANKS TO STEVE KUSHNER, ERIC KIM, DR. SUSANNA ALCAZAR-LEYVA, DR. JUAN FUNES, DR. PAUL CHEN, EVAN LEE, AUSTIN VERNACI, CALEB WILBORN, ARANTXA SANCHEZ
OUR MISSION
“We have developed transformational healing products that impact a modern world, including underprivileged individuals in third world countries. We will deliver a unique stand-alone broad-spectrum, topical lotion, for the treatment and care of a range of conditions and most skin injuries, including burns, as a basic human right.”
—Steven R. Schutt and John Everding, Founders
Copyright © 2024 LUMINEC HOLDINGS, INC. ALL RIGHTS RESERVED. ORIGINAL LUMINEC & NVRA LOGO CONCEPTS BY JOHN EVERDING • DESIGN BY SHARON TRAYNOR • THE NAMES, LOGOS, AND TAGLINES APPEARING ON THIS WEBSITE ARE THE EXCLUSIVE TRADEMARKS OF LUMINEC HOLDINGS, INC., AND MAY NOT BE USED WITHOUT THE EXPRESS PERMISSION OF LUMINEC HOLDINGS. OTHER TRADEMARKS AND LOGOS ARE COURTESY OF THEIR RESPECTIVE OWNERS •